Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey

Michal Shteinberg, Nili Stein, Yochai Adir, Shifra Ken-Dror, David Shitrit, Danielle Bendayan, Leonardo Fuks, Walid Saliba

Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017
Journal Issue: May
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Michal Shteinberg, Nili Stein, Yochai Adir, Shifra Ken-Dror, David Shitrit, Danielle Bendayan, Leonardo Fuks, Walid Saliba. Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey. Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020


The prevalence and clinical profile of non-tuberculous mycobacterial pulmonary infection in Singapore
Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer
Year: 2018

Nontuberculous mycobacterial disease: an important cause of morbi-mortality in HIV infected subjects
Source: Eur Respir J 2003; 22: Suppl. 45, 333s
Year: 2003

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016



Risk factors for fatal tuberculosis among immunocompetent patients.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017


What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020
Year: 2021



Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Tuberculous (TB) lymphadenitis: risk factors, diagnosis and outcomes in a low TB incidence area
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009

Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Prevalence and risk factors of frailty in patients with mycobacterium avium complex lung disease-preliminary study-
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018


Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study
Source: Eur Respir J, 55 (1) 1900798; 10.1183/13993003.00798-2019
Year: 2020



Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010


Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

The prevalence of latent pulmonary tuberculosis infection (LTBI) in low and high risk populations in Ireland
Source: Eur Respir J 2005; 26: Suppl. 49, 425s
Year: 2005

Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients
Source: Eur Respir J 2006; 28: 1211-1215
Year: 2006



Characteristics and risk factors for missed pulmonary tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


The risk factors in asthma patients for COVID19 infection
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021